CancerLinQ, LLC CEO, Kevin Fitzpatrick will join leaders of the cancer community including the Cancer Support Community and the American Cancer Society in speaking at the 2017 eyeforpharma Oncology Market Access & Pricing, taking place in Philadelphia.
ASCO in Action regularly provides the latest news and analysis related to cancer policy news; see the following online articles. These updates provide snapshots of ASCO’s ongoing advocacy efforts, as well as opportunities for ASCO members and guests to take action on critical issues affecting the cancer community.
To sign up for advocacy alerts, log in to ASCO.org with your ASCO member or guest account, and visit the subscription center available under your account profile.
CancerLinQ LLC is partnering with the leading association for hematology/oncology pharmacy professionals, the Hematology/Oncology Pharmacy Association (HOPA).
On March 15, HIMMS News published an article authored by CancerLinQ LLC Chief Operating Officer Rich Ross that discusses the need for interoperability to for big data efforts to be successful.
On March 22, ASCO’s big data initiative, CancerLinQ®, and newest journal, JCO Clinical Cancer Informatics (JCO CCI), will be highlighted at the Cancer Informatics for Cancer Centers (CI4CC) 2017 Spring Symposium and Workshop. This year’s meeting takes a focus on the role of registries in the national cancer data ecosystem.
ALEXANDRIA, Va. -- CancerLinQ LLC, a wholly-owned nonprofit subsidiary of the American Society of Clinical Oncology (ASCO), and the Oncology Nursing Society (ONS) announced today the formation of the CancerLinQ® Ambassadors Program. This new collaboration is a national practice engagement initiative that will provide on-the-ground support and guidance to CancerLinQ® participating practices on a regional basis.
CancerLinQ LLC and the American Society for Radiation Oncology (ASTRO) are partnering to bring radiation oncology expertise to CancerLinQ® and improve the care of cancer patients nationwide. ASTRO will provide guidance for the development of the CancerLinQ® platform to ensure that the system captures more relevant patient data to drive actionable decision-making in cancer care, as well as to advance public policy and population health issues. ASTRO also will use insights from CancerLinQ Discovery™ to improve the care of patients receiving radiation therapy.
CancerLinQ LLC, a wholly owned nonprofit subsidiary ASCO®, has announced that the University of Virginia (UVA) Cancer Center has signed an agreement to participate in the CancerLinQ® platform.
On February 14, SAP’s online course “The Future of Genomics and Precision Medicine” will begin, and enrollment for the free course is now open.
A new set of articles in the Journal of Oncology Practice seek to gain physicians and patients’ perspectives regarding the ethical implementation of a rapid learning system (RLS) in oncology care.
ASCO has submitted comments to the National Institutes of Health (NIH) in response to a Request for Information (RFI) on data sharing and management (NOT-OD-17-015).
On January 11, representatives from ASCO participated in the final event in the Cancer Moonshot℠ “Making Health Care Better” series, which focused on community oncology, at the White House.